| scholarly article | Q13442814 |
| P2093 | author name string | Fei Guo | |
| Jason D Tucker | |||
| Pei J Lu | |||
| Qi L Lu | |||
| Anthony R Blaeser | |||
| Elizabeth K Branch | |||
| P2860 | cites work | Dystroglycan function requires xylosyl- and glucuronyltransferase activities of LARGE | Q24301093 |
| Demonstration of mammalian protein O-mannosyltransferase activity: coexpression of POMT1 and POMT2 required for enzymatic activity | Q24303491 | ||
| B4GAT1 is the priming enzyme for the LARGE-dependent functional glycosylation of α-dystroglycan | Q24305043 | ||
| Reduced expression of dystroglycan in breast and prostate cancer | Q74421326 | ||
| Expression of dystroglycan correlates with tumor grade and predicts survival in renal cell carcinoma | Q80217804 | ||
| The glucuronyltransferase B4GAT1 is required for initiation of LARGE-mediated α-dystroglycan functional glycosylation | Q24305058 | ||
| Tumor suppressor function of laminin-binding alpha-dystroglycan requires a distinct beta3-N-acetylglucosaminyltransferase | Q24312078 | ||
| SGK196 is a glycosylation-specific O-mannose kinase required for dystroglycan function | Q24316126 | ||
| Human ISPD Is a Cytidyltransferase Required for Dystroglycan O-Mannosylation | Q27703190 | ||
| Human dystroglycan: skeletal muscle cDNA, genomic structure, origin of tissue specific isoforms and chromosomal localization | Q28257696 | ||
| Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix | Q28296676 | ||
| A novel human beta1,3-N-acetylgalactosaminyltransferase that synthesizes a unique carbohydrate structure, GalNAcbeta1-3GlcNAc | Q28511795 | ||
| The Muscular Dystrophy Gene TMEM5 Encodes a Ribitol β1,4-Xylosyltransferase Required for the Functional Glycosylation of Dystroglycan | Q32884430 | ||
| The functional O-mannose glycan on α-dystroglycan contains a phospho-ribitol primed for matriglycan addition | Q32884479 | ||
| Dystroglycan inside and out. | Q33744965 | ||
| A role for dystroglycan in epithelial polarization: loss of function in breast tumor cells. | Q33962881 | ||
| Adeno-associated virus-mediated overexpression of LARGE rescues α-dystroglycan function in dystrophic mice with mutations in the fukutin-related protein | Q34013566 | ||
| Differential glycosylation of α-dystroglycan and proteins other than α-dystroglycan by like-glycosyltransferase | Q34217566 | ||
| Like-acetylglucosaminyltransferase (LARGE)-dependent modification of dystroglycan at Thr-317/319 is required for laminin binding and arenavirus infection. | Q34223029 | ||
| Mutational and functional analysis of Large in a novel CHO glycosylation mutant | Q34983110 | ||
| Dystroglycan expression is frequently reduced in human breast and colon cancers and is associated with tumor progression. | Q35791328 | ||
| Dystroglycan complex in cancer | Q35837819 | ||
| Exome sequencing and functional validation in zebrafish identify GTDC2 mutations as a cause of Walker-Warburg syndrome | Q36439344 | ||
| Increased expression of CD133 and reduced dystroglycan expression are strong predictors of poor outcome in colon cancer patients. | Q36523671 | ||
| Loss of LARGE2 disrupts functional glycosylation of α-dystroglycan in prostate cancer. | Q36561917 | ||
| ISPD produces CDP-ribitol used by FKTN and FKRP to transfer ribitol phosphate onto α-dystroglycan | Q36919737 | ||
| Low glucose dependent decrease of apoptosis and induction of autophagy in breast cancer MCF-7 cells | Q36952559 | ||
| Loss of alpha-dystroglycan laminin binding in epithelium-derived cancers is caused by silencing of LARGE. | Q37160880 | ||
| Matriglycan: a novel polysaccharide that links dystroglycan to the basement membrane. | Q38424785 | ||
| Distinct functions of glial and neuronal dystroglycan in the developing and adult mouse brain. | Q38426779 | ||
| Correlation of deregulated like-acetylglucosaminyl transferase and aberrant α-dystroglycan expression with human tongue cancer metastasis | Q39015548 | ||
| Proteolytic enzymes and altered glycosylation modulate dystroglycan function in carcinoma cells. | Q40519860 | ||
| Aberrant expression, processing and degradation of dystroglycan in squamous cell carcinomas. | Q40519985 | ||
| Anomalous dystroglycan in carcinoma cell lines. | Q40842397 | ||
| Absence of α- and β-dystroglycan is associated with Walker-Warburg syndrome. | Q48197272 | ||
| Distinct expression of functionally glycosylated alpha-dystroglycan in muscle and non-muscle tissues of FKRP mutant mice. | Q48269884 | ||
| Tissue-specific heterogeneity in alpha-dystroglycan sialoglycosylation. Skeletal muscle alpha-dystroglycan is a latent receptor for Vicia villosa agglutinin b4 masked by sialic acid modification | Q48634703 | ||
| Identification of a Post-translational Modification with Ribitol-Phosphate and Its Defect in Muscular Dystrophy | Q48873234 | ||
| Increased expression of dystroglycan inhibits the growth and tumorigenicity of human mammary epithelial cells. | Q53364390 | ||
| Overexpression of Mutant FKRP Restores Functional Glycosylation and Improves Dystrophic Phenotype in FKRP Mutant Mice. | Q55440689 | ||
| Ribitol restores functionally glycosylated α-dystroglycan and improves muscle function in dystrophic FKRP-mutant mice | Q58701413 | ||
| Neural regulation of alpha-dystroglycan biosynthesis and glycosylation in skeletal muscle | Q73315875 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 1 | |
| P921 | main subject | cell growth | Q189159 |
| P304 | page(s) | 4935 | |
| P577 | publication date | 2020-03-18 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | Ribitol enhances matriglycan of α-dystroglycan in breast cancer cells without affecting cell growth | |
| P478 | volume | 10 |
Search more.